___

• Verbalis JG, Goldsmith SR, Greenberg A, et al.Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med 2013;126(10 Suppl 1):S1-42.
• Adrogué HJ, Madias NE. Hyponatremia. N Engl J Med ;342(21):1581–9.
• Upadhyay A, Jaber BL, Madias NE. Incidence and prevalence of hyponatremia. Am J Med 2006;119(1):30-5.
• Schrier RW, Berl T, Anderson RJ. Osmotic and nonosmotic control of vasopressin release. Am J Physiol 1979;236(4):321-32.
• Abramow M, Cogan E. Clinical aspects and pathophysiology of diüretic hyponatremia. Adv Nephrol Necker Hosp 1984;13(1):1
• Luzecky MH, Burman KD, Schultz ER. The syndrome of inappropriate secretion of antidiuretic hprmone associated with amitriptyline administration. South Med J 1974:67(4):495
• Steinhoff BJ, Stoll KD, Stodieck SR, Paulus W. Hyponatremic coma under oxcarbazepine therapy. Epilesy Res 1992;11(1):67
• Liamis G, Milionis H, Elisaf M. Review of drug-induced hyponatremia. American Journal of Kidney Diseases ;52(1):144-53. Robert WS(Editör). Böbrek ve elektrolit hastalıkları. In: Tomas B, Robert WS. Su metabolizma bozuklukları. 6ncı Baskı, Ankara: Güneş Tıp Kitabevi, 2005:1-54.
• Williams JD. Beta-lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone. Clin Infect Dis ;24(3):494-7. Kumar AV, Rao NR. Cefoperazone induced gastrointestinal haemorrhage. J Assoc Physic India 1999;47(8):840-1.
• Rault RM. Case report: hyponatremia associated with nonsteroidal antiinflammatory drugs. Am J Med Sci ;305(5):318-20. Kirch C, Gachot B, Germann N, Blot F, Nitenberg G. Recurrent ifosfamide-induced hyponatraemia. Eur J Cancer ;33(14):2438-9.
• Schwab M, Ruder H. Hyponatraemia and cerebral convulsion due to DDAVP administration in patients with enuresis nocturna or urine concentration testing. Eur J Pediatr 1997;156(8):668.
• Mitra S, Basu S. Cefoperazone / sulbactam induced